Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Thrombosis and Thrombolysis
Literature
1.
Clarkson TW, Magos L (2006) The toxicology of mercury and its chemical compounds. Crit Rev Toxicol 36:609–662CrossRef
2.
Mitra P, Sharma S, Purohit P, Sharma P (2017) Clinical and molecular aspects of lead toxicity: an update. Crit Rev Clin Lab Sci 54:506–528CrossRef
3.
Ye BJ, Kim BG, Jeon MJ, Kim SY, Kim HC, Jang TW, Chae H, Choi WJ, Ha MN, Hong YS (2016) Evaluation of mercury exposure level, clinical diagnosis and treatment for mercury intoxication. Ann Occup Environ Med 28:5CrossRef
4.
Shefa ST, Héroux P (2017) Both physiology and epidemiology support zero tolerable blood lead levels. Toxicol Lett 280:232–237CrossRef
5.
Nuttall KL (2004) Interpreting mercury in blood and urine of individual patients. Ann Clin Lab Sci 34:235–250PubMed
6.
DiMaio VJ, DiMaio SM, Garriott JC, Simpson P (1983) A fatal case of lead poisoning due to a retained bullet. Am J Forensic Med Pathol 4:165–169CrossRef
7.
Worowski K (1968) The hypercoagulability in mercury chloride intoxicated dogs. Thromb Diath Haemorrh 19:236–241CrossRef
8.
Kostka B, Michalska M, Krajewska U, Wierzbicki R (1989) Blood coagulation changes in rats poisoned with methylmercuric chloride (MeHg). Pol J Pharmacol Pharm 41:183–189PubMed
9.
Kostka B, Krajewska U, Rieske P (1997) Platelet activation by mercuric compounds. Platelets 8:413–417CrossRef
10.
Wennberg M, Strömberg U, Bergdahl IA, Jansson JH, Kauhanen J, Norberg M, Salonen JT, Skerfving S, Tuomainen TP, Vessby B, Virtanen JK (2012) Myocardial infarction in relation to mercury and fatty acids from fish: a risk-benefit analysis based on pooled Finnish and Swedish data in men. Am J Clin Nutr 96:706–713CrossRef
11.
Köklü S, Aksoy DY, Altundag K, Usalan C (2003) Superior vena cava thrombosis in chronic lead exposure: a case report. Angiology 54:481–483CrossRef
12.
Al Momen A (2010) Thrombocytosis secondary to chronic lead poisoning. Platelets 21:297–299CrossRef
13.
Nielsen VG, Pretorius E (2014) Iron and carbon monoxide enhance coagulation and attenuate fibrinolysis by different mechanisms. Blood Coagul Fibrinolysis 25:695–702CrossRef
14.
Nielsen VG, Ward TD, Ford PM (2018) Effects of cupric chloride on coagulation in human plasma: role of fibrinogen. J Thromb Thrombolysis 46:359–364CrossRef
Metadata
Title
Lethal concentrations of mercury or lead do not affect coagulation kinetics in human plasma
Author
Vance G. Nielsen
Publication date
01-11-2019
Publisher
Springer US
Keyword
Intoxication
Published in
Journal of Thrombosis and Thrombolysis / Issue 4/2019
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-019-01921-x

Other articles of this Issue 4/2019

Journal of Thrombosis and Thrombolysis 4/2019 Go to the issue

OriginalPaper

Survey of confidence in use of stroke and bleeding risk calculators, knowledge of anticoagulants, and comfort with prescription of anticoagulation in challenging scenarios: SUPPORT-AF II study

OriginalPaper

Venous thromboembolism 2011–2018 in Stockholm: a demographic study

ReviewPaper

A narrative review of red blood cell distribution width as a marker for pulmonary embolism

Report

First evidence for a pharmacist-led anticoagulant clinic in a medicare part A long term care environment

OriginalPaper

Assessment of warfarin algorithms for hospitalized adults: searching for a safe dosing strategy

OriginalPaper

Assessment of preoperative hypercoagulability in patients with pancreatic ductal adenocarcinoma (PDAC) using rapid thromboelastography (r-TEG)
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits